Scarica l'app Stockscreener
0.00
100.00%
-0.1426
Precedente Chiudi:
$0.1426
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$7.90M
Reddito:
$3.10M
Utile/perdita netta:
$-97.43M
Rapporto P/E:
0.00
EPS:
-1.8
Flusso di cassa netto:
$-94.38M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$2.625
Omega Therapeutics Inc Stock (OMGA) Company Profile
Nome
Omega Therapeutics Inc
Settore
Industria
Telefono
(617) 949-4360
Indirizzo
140 FIRST STREET, SUITE 501, CAMBRIDGE
Confronta OMGA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.00 | 7.90M | 3.10M | -97.43M | -94.38M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | Iniziato | Raymond James | Outperform |
| 2023-05-25 | Ripresa | Jefferies | Buy |
| 2022-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-09-23 | Iniziato | Chardan Capital Markets | Buy |
Omega Therapeutics Inc Borsa (OMGA) Ultime notizie
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Omega Therapeutics (NASDAQ:OMGA) Shares Down 21.8% – Here’s Why - Defense World
Key healthcare company files for Chapter 11 bankruptcy - TheStreet
Life-saving healthcare company files for Chapter 11 bankruptcy - MSN
Liver Cancer Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
Omega Therapeutics (NASDAQ:OMGA) Trading Down 21.8% – Time to Sell? - Defense World
Biotech Firm Omega Therapeutics OK'd For $14M Ch. 11 Sale - Law360
Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace
Recursion Pharmaceuticals (NASDAQ:RXRX) & Omega Therapeutics (NASDAQ:OMGA) Critical Analysis - Defense World
Flagship-backed Sail Biomedicines lays off staff following review of organizational structure - Fierce Biotech
OMEGA THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Omega Therapeutics (OMGA) Projected to Post Earnings on Thursday - The AM Reporter
Solving CNS delivery will open big doors for epigenome editing: a Perspective - BioCentury
Omega Therapeutics (OMGA) to Release Quarterly Earnings on Thursday - Defense World
Flagship's Empress lays off 53% of staffers in push to get science to clinic - Fierce Biotech
Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline development - Fierce Biotech
Omega Therapeutics secures $9.8M in DIP financing - MSN
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases - Nature
Lila Sciences raises $200M to accelerate autonomous scientific research - SiliconANGLE
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
Struggling healthcare firm files for Chapter 11 bankruptcy - TheStreet
OMEGA THERAPEUTICS INC Revenue Breakdown – OTC:OMGAQ - TradingView
Two new option listings and eighteen option delistings on February 25th - TipRanks
Omega Therapeutics to sell assets amid Nasdaq delisting By Investing.com - Investing.com India
Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology - GlobeNewswire
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Vaccine Developer Files Ch. 11 Sale Plan With $11.5M Bid - Law360
Omega Therapeutics Inc Azioni (OMGA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):